FIGURE 2
FROM:
MCM immunocytochemistry as a first line cervical screening test in developing countries: a prospective cohort study in a regional cancer centre in India
G Mukherjee, B Muralidhar, U D Bafna, R A Laskey and N Coleman
BACK TO ARTICLEFigure 2.
(A and B) Representative images of the immunoenhanced Pap test, showing MCM-positive cells at (A) low power and (B) high power.
